Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
British Journal of Pharmacology
|
May 12, 2011
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats
Maria Scherma, Zuzana Justinová, Claudio Zanettini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 22, 2020
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine
Maria Scherma, Johanna S Qvist, Arun Asok, et al.
Biological Psychiatry
|
August 31, 2010
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors
Paola Mascia, Marco Pistis, Zuzana Justinova, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 30, 2008
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats
Maria Scherma, Leigh V Panlilio, Paola Fadda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 5, 2013
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors
Miriam Melis, Simona Scheggi, Gianfranca Carta, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 25, 2022
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
Ulker Isayeva, Mirko Manchia, Roberto Collu, et al.
Brain Sciences
|
December 23, 2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
Mirko Manchia, Ulker Isayeva, Roberto Collu, et al.
Schizophrenia Research
|
February 29, 2024
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data
Ulker Isayeva, Mirko Manchia, Roberto Collu, et al.
Nature Neuroscience
|
October 15, 2013
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
Zuzana Justinova, Paola Mascia, Hui-Qiu Wu, et al.
International Journal of Molecular Sciences
|
July 27, 2024
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study
Pasquale Paribello, Mirko Manchia, Ulker Isayeva, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
British Journal of Pharmacology
|
May 12, 2011
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats
Maria Scherma, Zuzana Justinová, Claudio Zanettini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 22, 2020
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine
Maria Scherma, Johanna S Qvist, Arun Asok, et al.
Biological Psychiatry
|
August 31, 2010
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors
Paola Mascia, Marco Pistis, Zuzana Justinova, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 30, 2008
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats
Maria Scherma, Leigh V Panlilio, Paola Fadda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 5, 2013
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors
Miriam Melis, Simona Scheggi, Gianfranca Carta, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 25, 2022
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
Ulker Isayeva, Mirko Manchia, Roberto Collu, et al.
Brain Sciences
|
December 23, 2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
Mirko Manchia, Ulker Isayeva, Roberto Collu, et al.
Schizophrenia Research
|
February 29, 2024
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data
Ulker Isayeva, Mirko Manchia, Roberto Collu, et al.
Nature Neuroscience
|
October 15, 2013
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
Zuzana Justinova, Paola Mascia, Hui-Qiu Wu, et al.
International Journal of Molecular Sciences
|
July 27, 2024
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study
Pasquale Paribello, Mirko Manchia, Ulker Isayeva, et al.
Page
of 8